AKT1 and diabetic ketoacidosis: Diabetic ketoacidosis (DKA) is a serious metabolic emergency typically seen in patients with diabetes mellitus; however, emerging reports suggest that certain targeted therapies, including AKT inhibitors such as capivasertib, can induce DKA even in non-diabetic individuals [1].